Athanor Capital, LP Solid Biosciences Inc. Transaction History

Athanor Capital, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.49 - $5.51 $42,550 - $67,177	-12,192 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$5.37 - $10.72 $10,079 - $20,121	1,877 Added 18.2%	12,192 $67,000
Q4 2020 Feb 16, 2021	BUY	$3.08 - $7.79 $31,770 - $80,353	10,315 New	10,315 $78,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $36.5M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.